2021
DOI: 10.32607/actanaturae.11337
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Diversity and Evolution of the Biological Features of the Pandemic SARS-CoV-2

Abstract: The new coronavirus infection (COVID-19) represents a challenge for global health. Since the outbreak began, the number of confirmed cases has exceeded 117 million, with more than 2.6 million deaths worldwide. With public health measures aimed at containing the spread of the disease, several countries have faced a crisis in the availability of intensive care units. Currently, a large-scale effort is underway to identify the nucleotide sequences of the SARS-CoV-2 coronavirus that is an etiological agent of COVI… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 96 publications
0
0
0
Order By: Relevance
“…There are many published reports available describing the comparative study of genetic determinants with high-and low-virulence properties and mortality rates caused by HCoVs like SARS-CoV-1, SARS-CoV-2, and MERS-CoV in comparison to other HCoVs like HCoV-NL63, -229E, -OC43, and -HKU1 [53]. Global viromics studies of more than 3000 viral genomes collected from both humans and animals (SARS-CoV-1, MERS-CoV, and SARS-CoV-2) confirmed variations in four locations situated in the nucleoprotein gene (N) and S protein gene as compared to HCoV-NL63, -229E, -OC43, and -HKU1 [47,53]. The WHO has kept MERS-CoV on the priority list for performing detailed studies because of its continuous infection and spread to humans and camels in different locations [22].…”
Section: Discussionmentioning
confidence: 78%
See 2 more Smart Citations
“…There are many published reports available describing the comparative study of genetic determinants with high-and low-virulence properties and mortality rates caused by HCoVs like SARS-CoV-1, SARS-CoV-2, and MERS-CoV in comparison to other HCoVs like HCoV-NL63, -229E, -OC43, and -HKU1 [53]. Global viromics studies of more than 3000 viral genomes collected from both humans and animals (SARS-CoV-1, MERS-CoV, and SARS-CoV-2) confirmed variations in four locations situated in the nucleoprotein gene (N) and S protein gene as compared to HCoV-NL63, -229E, -OC43, and -HKU1 [47,53]. The WHO has kept MERS-CoV on the priority list for performing detailed studies because of its continuous infection and spread to humans and camels in different locations [22].…”
Section: Discussionmentioning
confidence: 78%
“…The monitoring of HCoV infections at a molecular level with an emphasis on the genome and phylogeny enables us to elucidate the emergence of new variants/strains that may infect and cause diseases to new hosts, including animals and humans at different geographic locations. Seasonal HCoVs such as HCoV-NL63, -229E, -OC43, and -HKU1 cause only seasonal infections, while SARS-CoV-1, MERS-CoV, and SARS-CoV-2 are known to cause respiratory illnesses throughout the year [2,22,47,48]. Genetic changes in the viral genomes lead to disruption of the virus-and-host cell interactions, as well as changes in virus reproduction, virulence, pathogenicity, gene expression, and ultimately determine the outcome of the severe infection [47].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, it turns out that the space of variants available to the SARS-CoV-2 coronavirus is quite narrow, and the trajectories of its development may be determined to some extent. Indeed, the SARS-CoV-2 genome has been shown to have a much lower mutation rate and genetic diversity compared to the SARS-CoV virus that caused the atypical pneumonia outbreak in 2002-2003(Jia et al, 2020Zhou et al, 2020;Nikonova et al, 2021). Thus, for example, for the SARS-CoV-2 S-protein, the d N and d S values appeared to be approximately 12 and 7 times lower than those for SARS-CoV (where d N is the fraction of sequences in a sample of genomes that contain non-synonymous mutations in a particular gene; d S is a similar value, but for synonymous mutations).…”
Section: Discussionmentioning
confidence: 99%